ARTICLE | Distillery Therapeutics
Therapeutics: Flavin containing monooxygenase 3 (FMO3)
May 14, 2015 7:00 AM UTC
In vitro, mouse and patient sample studies suggest inhibiting FMO3 could help prevent or treat diabetes-associated atherosclerosis. Liver levels of FMO3 were higher in diabetes patients and several mo...